Max Robotics — Global Service Robot Directory + US Certification

About

Luca Felicioni is a pioneering surgeon whose career has been defined by advancing the frontiers of robotic-assisted surgery, particularly in complex oncologic and vascular procedures. His most impactful work focuses on the application of robotic technology to gastric cancer treatment, where he has demonstrated significant long-term benefits. Felicioni’s landmark 2015 study, with 58 citations, provided crucial five-year follow-up data proving the durability and oncologic safety of robotic gastrectomy. Earlier, his 2006 research on advanced gastric cancer (18 citations) established that robotic techniques could improve early survival rates for patients with aggressive disease. Beyond oncology, Felicioni has been instrumental in redefining the standard of care for visceral aneurysms, with his 2006 and 2011 papers (totaling 36 citations) showing that robotic treatment offers a safer, less invasive alternative to traditional open surgery. His recent work on robotic abdominal wall reconstruction (2023, 10 citations) further demonstrates his commitment to expanding the scope of minimally invasive surgery. Through these contributions, Felicioni has not only accumulated over 120 citations but has also helped establish robotic surgery as a viable, often superior, option for treating some of the most challenging surgical conditions.